Author:
Safirstein Robert,Deray Gilbert
Reference79 articles.
1. Meijer S, Mulder NH, Sleijfer DT, de Jong PE, Sluiter WJ, Schraffordt Koops H, van der Hem GK. Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of the testicular carcinoma. Cancer Chemother Pharmacol 1982; 8: 27–30.
2. Brock PR, Koliouska DE, Baratt TM, Yeomans E, Pritchard J. Partial reversibility of cisplatin nephrotoxicity in children. J Pediatric 1991; 118: 531–4.
3. Yuhas JM, Culo F. Selective inhibition of the nephrotoxicity of cis-dichlorodiamine platinum by WR 2721 without altering its antitumor properties. Cancer Treat Rep 1980; 64: 57–64.
4. Borch RF, Pleasants ME. Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat renal model. Proc Natl Acad Sci USA 1979; 76: 6611–4.
5. Berry J-P, Pauwells C, Tlouzeau S, Lespinats G. Effect of Selenium in combination with cis-diamminedich-loroplatinum (II) in the treatment of murine fibrosarcoma. Cancer Res 1984; 44: 2864–8.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacological aspects of nephrotoxicity;Clinical Nephrotoxins;2008
2. Anticancer drugs;Clinical Nephrotoxins;2008
3. Anticancer drugs;Clinical Nephrotoxins;2003